biogen idec research limited

Live EstablishedMicroDeclining

biogen idec research limited Company Information

Share BIOGEN IDEC RESEARCH LIMITED

Company Number

07588215

Shareholders

biogen ma inc.

Group Structure

View All

Industry

Other research and experimental development on natural sciences and engineering

 

Registered Address

building 5 foundation park, roxborough way, maidenhead, berkshire, SL6 3UD

biogen idec research limited Estimated Valuation

£6.2k

Pomanda estimates the enterprise value of BIOGEN IDEC RESEARCH LIMITED at £6.2k based on a Turnover of £7.8k and 0.8x industry multiple (adjusted for size and gross margin).

biogen idec research limited Estimated Valuation

£3.7k

Pomanda estimates the enterprise value of BIOGEN IDEC RESEARCH LIMITED at £3.7k based on an EBITDA of £1k and a 3.65x industry multiple (adjusted for size and gross margin).

biogen idec research limited Estimated Valuation

£627.2k

Pomanda estimates the enterprise value of BIOGEN IDEC RESEARCH LIMITED at £627.2k based on Net Assets of £308.4k and 2.03x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Biogen Idec Research Limited Overview

Biogen Idec Research Limited is a live company located in maidenhead, SL6 3UD with a Companies House number of 07588215. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in April 2011, it's largest shareholder is biogen ma inc. with a 100% stake. Biogen Idec Research Limited is a established, micro sized company, Pomanda has estimated its turnover at £7.8k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Biogen Idec Research Limited Health Check

Pomanda's financial health check has awarded Biogen Idec Research Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

3 Strong

positive_score

0 Regular

positive_score

5 Weak

size

Size

annual sales of £7.8k, make it smaller than the average company (£4.3m)

£7.8k - Biogen Idec Research Limited

£4.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (6.8%)

-3% - Biogen Idec Research Limited

6.8% - Industry AVG

production

Production

with a gross margin of 13%, this company has a higher cost of product (46.9%)

13% - Biogen Idec Research Limited

46.9% - Industry AVG

profitability

Profitability

an operating margin of 13% make it more profitable than the average company (3.6%)

13% - Biogen Idec Research Limited

3.6% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (44)

2 - Biogen Idec Research Limited

44 - Industry AVG

paystructure

Pay Structure

There is insufficient data available for this Key Performance Indicator!

- - Biogen Idec Research Limited

- - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £3.9k, this is less efficient (£124k)

£3.9k - Biogen Idec Research Limited

£124k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Biogen Idec Research Limited

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Biogen Idec Research Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Biogen Idec Research Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 9869 weeks, this is more cash available to meet short term requirements (32 weeks)

9869 weeks - Biogen Idec Research Limited

32 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 0.5%, this is a lower level of debt than the average (44.4%)

0.5% - Biogen Idec Research Limited

44.4% - Industry AVG

BIOGEN IDEC RESEARCH LIMITED financials

EXPORTms excel logo

Biogen Idec Research Limited's latest turnover from December 2023 is £7.8 thousand and the company has net assets of £308.4 thousand. According to their latest financial statements, Biogen Idec Research Limited has 2 employees and maintains cash reserves of £284.5 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011
Turnover7,7897,6647,6888,5259,29518,95972,620527,8531,188,252807,3171,025,661900,630424,285
Other Income Or Grants
Cost Of Sales6,77811,5984,1604,7294,95910,09438,919281,646641,977452,909558,581504,962234,410
Gross Profit1,011-3,9343,5293,7974,3368,86533,701246,207546,274354,408467,080395,668189,875
Admin Expenses7,5435758,00018,30630,382235,982433,605283,196378,955329,035150,375
Operating Profit1,011-3,934-4,0143,222-3,664-9,4413,31910,225112,66971,21288,12566,63339,500
Interest Payable
Interest Receivable6,8791,040
Pre-Tax Profit7,890-2,894-4,0143,222-3,664-9,4413,31910,225112,66971,21288,12566,63339,500
Tax14,404-17,450-68,654-26,683-780-10,269
Profit After Tax7,890-2,894-4,0143,222-3,6644,9643,31910,22595,2192,55861,44265,85329,230
Dividends Paid
Retained Profit7,890-2,894-4,0143,222-3,6644,9643,31910,22595,2192,55861,44265,85329,230
Employee Costs235,956234,361
Number Of Employees2221222224555
EBITDA*1,011-3,934-4,0143,222-3,664-9,4413,31910,225112,66971,21288,12566,63339,500

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
Group Debtors25,37125,80625,13637,19115,79514,09167,874200,463483,241180,741131,040145,668424,285
Misc Debtors1,0611,0681,1901,9042,0827,050
Cash284,498276,173281,619309,232268,268300,441294,718286,181249,793187,122168,46696,910
misc current assets
total current assets309,869303,040307,824347,615285,967316,615369,643486,645733,034367,863299,506242,579424,285
total assets309,869303,040307,824347,615285,967316,615369,643486,645733,034367,863299,506242,579424,285
Bank overdraft
Bank loan
Trade Creditors 5,2222,891
Group/Directors Accounts57,991186,413435,095171,364134,705143,495381,894
other short term finances
hp & lease commitments
other current liabilities1,4985,1369,5984,9372,70010,269
total current liabilities1,49957,991191,549444,693176,301137,405148,717395,055
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities1,49957,991191,549444,693176,301137,405148,717395,055
net assets308,370303,040307,824347,615285,967316,615311,652295,095288,341191,562162,10193,86229,230
total shareholders funds308,370303,040307,824347,615285,967316,615311,652295,095288,341191,562162,10193,86229,230
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011
Operating Activities
Operating Profit1,011-3,934-4,0143,222-3,664-9,4413,31910,225112,66971,21288,12566,63339,500
Depreciation
Amortisation
Tax14,404-17,450-68,654-26,683-780-10,269
Stock
Debtors-1,496663-12,17820,6831,526-58,752-125,538-282,778302,50049,701-14,628-278,617424,285
Creditors-5,2222,3312,891
Accruals and Deferred Income1,498-5,136-4,4624,6612,2372,700-10,26910,269
Deferred Taxes & Provisions
Cash flow from operations4,005-4,5978,164-17,461-5,19063,715123,721288,541-202,620-44,90673,548336,532-381,894
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts-57,991-128,423-248,682263,73136,659-8,791-238,399381,894
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue-2,560-1,889-35,77758,425-26,98413,237-3,4701,56026,9026,798-1,222
interest6,8791,040
cash flow from financing4,319-849-35,77758,425-26,984-57,991-115,186-252,152265,29163,561-1,993-239,621381,894
cash and cash equivalents
cash8,325-5,446-27,61340,965-32,1745,7248,53736,38862,67118,65671,55596,910
overdraft
change in cash8,325-5,446-27,61340,965-32,1745,7248,53736,38862,67118,65671,55596,910

biogen idec research limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for biogen idec research limited. Get real-time insights into biogen idec research limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Biogen Idec Research Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for biogen idec research limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SL6 area or any other competitors across 12 key performance metrics.

biogen idec research limited Ownership

BIOGEN IDEC RESEARCH LIMITED group structure

Biogen Idec Research Limited has no subsidiary companies.

Ultimate parent company

BIOGEN IDEC INC.

#0112285

BIOGEN MA INC

#0069488

2 parents

BIOGEN IDEC RESEARCH LIMITED

07588215

BIOGEN IDEC RESEARCH LIMITED Shareholders

biogen ma inc. 100%

biogen idec research limited directors

Biogen Idec Research Limited currently has 2 directors. The longest serving directors include Dr John Way (Aug 2021) and Mr Geronimo Martinez (Sep 2023).

officercountryagestartendrole
Dr John WayEngland51 years Aug 2021- Director
Mr Geronimo MartinezEngland39 years Sep 2023- Director

P&L

December 2023

turnover

7.8k

+2%

operating profit

1k

-126%

gross margin

13%

-125.29%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

308.4k

+0.02%

total assets

309.9k

+0.02%

cash

284.5k

+0.03%

net assets

Total assets minus all liabilities

biogen idec research limited company details

company number

07588215

Type

Private limited with Share Capital

industry

72190 - Other research and experimental development on natural sciences and engineering

incorporation date

April 2011

age

14

incorporated

UK

ultimate parent company

BIOGEN IDEC INC.

accounts

Full Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

PRICEWATERHOUSECOOPERS LLP

address

building 5 foundation park, roxborough way, maidenhead, berkshire, SL6 3UD

Bank

BANK OF AMERICA

Legal Advisor

-

biogen idec research limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to biogen idec research limited.

biogen idec research limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BIOGEN IDEC RESEARCH LIMITED. This can take several minutes, an email will notify you when this has completed.

biogen idec research limited Companies House Filings - See Documents

datedescriptionview/download